Subscribe

Spotlight -

Ronald van Vollenhoven, PhD

Articles by Ronald van Vollenhoven, PhD

Systemic Lupus Erythematosus Treatment Advances: Anifrolumab

ByFotios Koumpouras, MD, FACR,Ronald van Vollenhoven, PhD

March 18th 2022

The rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.

Latest Updated Articles

Systemic Lupus Erythematosus Treatment Advances: Anifrolumab
March 18th 2022

Trending on Rheumatology Live

Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More